Skip to main content
. Author manuscript; available in PMC: 2023 Jun 1.
Published in final edited form as: Exp Clin Psychopharmacol. 2021 Feb 25;30(3):269–278. doi: 10.1037/pha0000440

Appendix Table A.

Clinically Significant Insomnia Scores (ISI > 14) on IDQ-S Subscales

IDQ-Sc –Lack of Cognitive Coping IDQ-Sc –Withdrawal Intolerance

Variable β t p β t p

Gender −.009 −.127 .899 −.155 −2.464 .015
Age .002 .030 .976 −.110 −1.773 .078
Race −.031 −.454 .650 −.071 −1.139 .256
HSIa .136 1.955 .052 .202 3.158 .002
DIIb −.065 −.929 .354 .116 1.810 .072
Clinically significant ISI −.058 −.837 .403 .220 3.484 .001
R 2 .022 .176
ΔR2 .003 .046
F for ΔR2 .701 12.137**

Note: N = 224. Results shown are from the second step of each linear regression model; p = standardized beta weights; Race: Reference group = white; Gender: Reference group = female; Clinically significant ISI: Reference group = no clinical insomnia

a

Heaviness of Smoking Index

b

Distress Intolerance Index

c

Intolerance for Smoking Abstinence Discomfort Questionnaire

*

p < .05

**

p < .01